I have four years experience working in the area of topical and transdermal drug delivery. My experience also includes work on the formulation and process development of solid dosage forms (tablet, capsule, granule), liquid oral (solution and suspension) topical (ointment and cream) and sterile injection (solution) dosage forms. My research areas include 1 topical and transdermal drug delivery including formulation design and development, Formulation of nanoparticles for drug delivery applications. I am also interested in dermatotoxicity of nanomaterials, chemicals, drugs and pharmaceuticals and improvement of solubility and bioavailability of insoluble drugs. Selected Research Publications (published papers with the name: “Babu RJ”) Sathigari S, Chadha G, Lee YH, Wright N, Parsons DL, Rangari VK, Fasina O, Babu RJ. Physicochemical Characterization of Efavirenz-Cyclodextrin Inclusion Complexes. AAPS PharmSciTech. 2009: Jan 16. [Epub ahead of print] Babu RJ, Dayal P, Singh M. Effect of cyclodextrins on the complexation and nasal permeation of melatonin. Drug Deliv. 2008: 15: 381-8. Fulzele SV, Babu RJ, Ahaghotu E, Singh M. Estimation of proinflammatory biomarkers of skin irritation by dermal microdialysis following exposure with irritant chemicals. Toxicology. 2007: 237: 77-88.